A large South African multicentre study of the Kheth’Impilo cohort conducted across both urban and rural areas showed that a lower proportion of older patients (in this study > 55 years) had CD4+ counts of < 50 cells/mm3, WHO stage 4 disease and TB treatment at baseline. This evidence concerns the gene CD4 and tuberculosis.